Pfizer Inc (NYSE:PFE)

31.83
Data as of Jan 29
 -0.12 / -0.38%
Today’s Change
27.51
Today|||52-Week Range
33.50
+2.18%
Year-to-Date
Too Much Market Craziness at Once
Jan 29 / TheStreet.com
Pfizer (PFE) Is Today's Pre-Market Laggard Stock
Jan 27 / TheStreet.com
Too Much Market Craziness at Once
Jan 29 / TheStreet.com
Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead
Jan 27 / MotleyFool.com
Getting Defensive Now
Jan 29 / TheStreet.com
Stock Futures Tumble as Earnings From Blue Chips Disappoint
Jan 27 / TheStreet.com
Is The Dollar Really As Strong As Companies Are Suggesting?
Jan 28 / Benzinga
Earnings Scheduled For January 27, 2015
Jan 27 / Benzinga
Pfizer (PFE) Is Water-Logged And Getting Wetter Today
Jan 28 / TheStreet.com
Stock set to open significantly lower
Jan 27 / CNNMoney.com
What You Need To Know About The Spark Therapeutics IPO
Jan 28 / Benzinga
10 Stocks You Should Be Watching Today
Jan 27 / Benzinga
3 Stocks Underperforming Today In The Drugs Industry
Jan 28 / TheStreet.com
Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog
Jan 26 / Zacks.com
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Resea...
Jan 28 / Zacks.com
Pfizer Commits to Further Reduce Price for Prevenar 13 in the World's Poorest Countri...
Jan 26 / Benzinga
Revenge of the Dollar
Jan 28 / TheStreet.com
What to Expect When Pfizer (PFE) Reports Fourth-Quarter Earnings Tomorrow
Jan 26 / TheStreet.com
Stock Market News for January 28, 2015 - Market News
Jan 28 / Zacks.com
Currency market swings hit global effort to fund vaccinations
Jan 26 / FT.com
The One Thing Pfizer, Inc. Shareholders Should Worry About, and One They Shouldn't
Jan 28 / MotleyFool.com
Frontrunning: January 26
Jan 26 / Investing Channel
PFIZER INC (PFE) Earnings Report: Q4 2014 Conference Call Transcript
Jan 27 / TheStreet.com
Market Wrap: Global Risk Rattled By Syriza Surge To Power
Jan 26 / Investing Channel
Pfizer chief says big acquisition not required
Jan 27 / FT.com
Benzinga's Weekend M&A Chatter
Jan 25 / Benzinga
Pfizer Spikes On $13 Billion Plan For Buybacks, Dividends
Jan 27 / Benzinga
These 3 Dividend Stocks Could Crush the Market in 2015
Jan 24 / MotleyFool.com
Tighten Those Chin Straps Folks Because Here Comes a Rapid Unscheduled Disassembly (R...
Jan 27 / Investing Channel
This Stock Could Become the Next Johnson & Johnson
Jan 24 / MotleyFool.com
Dow Plunges Over 300 Points as Microsoft Puts the PC Back on Death Row
Jan 27 / MotleyFool.com
Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog
Jan 23 / Zacks.com
Pfizer Warns on Outlook but Analysts Optimistic: What Wall Street's Saying
Jan 27 / TheStreet.com
Will Oncology Products Drive Bristol-Myers (BMY) Earnings? - Analyst Blog
Jan 23 / Zacks.com
Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog
Jan 27 / Zacks.com
Will Pfizer (PFE) Beat Q4 Earnings Despite Generics? - Analyst Blog
Jan 23 / Zacks.com
Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog
Jan 27 / Zacks.com
Why Earnings Season Could Be Great for Pfizer (PFE) - Tale of the Tape
Jan 23 / Zacks.com
Tuesday Morning Movers: Microsoft, Procter & Gamble Tumble Following Earnings
Jan 27 / Benzinga
Without Question, This Company Puts Its Shareholders First
Jan 23 / MotleyFool.com
Pfizer (PFE) Stock Volatile Today After Fourth-Quarter Earnings Beat, Weak 2015 Guida...
Jan 27 / TheStreet.com
Immunomedics Reports Data on Oncology Candidate - Analyst Blog
Jan 21 / Zacks.com
Pfizer Inc.'s Fourth-Quarter Earnings Hint at Big Things to Come
Jan 27 / MotleyFool.com
State of the Union Address Investing Idea: Precision Medicine
Jan 21 / MotleyFool.com
UPDATE: Pfizer Posts Better-Than-Expected Q4 Earnings, But Issues Weak Outlook
Jan 27 / Benzinga
Thanks, Obamacare! Health insurer stocks soar
Jan 21 / CNNMoney.com
Pfizer (PFE) Beats on Q4 Earnings, Shares Slip on Guidance - Tale of the Tape
Jan 27 / Zacks.com
MannKind Corporation on Track for Afrezza Launch
Jan 21 / MotleyFool.com
Market Wrap: Futures Tumble On Spike Of "Strong Dollar" Earnings Disappointments And ...
Jan 27 / Investing Channel
Will Pharmaceutical Segment Drive J&J Q4 Earnings Again? - Analyst Blog
Jan 19 / Zacks.com

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.